CATALOGO DEI PRODOTTI DELLA RICERCA

BASSI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 43.180
NA - Nord America 36.446
AS - Asia 24.661
SA - Sud America 3.223
AF - Africa 616
OC - Oceania 100
Continente sconosciuto - Info sul continente non disponibili 29
AN - Antartide 2
Totale 108.257
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.778
RU - Federazione Russa 12.491
IT - Italia 10.125
SG - Singapore 10.013
GB - Regno Unito 9.033
CN - Cina 7.673
BR - Brasile 2.579
DE - Germania 2.280
HK - Hong Kong 2.062
FR - Francia 2.026
SE - Svezia 1.990
VN - Vietnam 1.937
IE - Irlanda 1.664
FI - Finlandia 1.421
KR - Corea 776
UA - Ucraina 541
NL - Olanda 426
IN - India 378
CA - Canada 344
JP - Giappone 324
TR - Turchia 276
AR - Argentina 241
MX - Messico 215
BD - Bangladesh 200
ES - Italia 182
PL - Polonia 180
ID - Indonesia 160
ZA - Sudafrica 141
IQ - Iraq 139
BE - Belgio 136
NG - Nigeria 134
AT - Austria 129
CZ - Repubblica Ceca 104
PK - Pakistan 99
EC - Ecuador 97
AU - Australia 83
UZ - Uzbekistan 80
CH - Svizzera 79
SA - Arabia Saudita 78
VE - Venezuela 72
CO - Colombia 65
LT - Lituania 58
MA - Marocco 55
CL - Cile 50
IR - Iran 49
TG - Togo 48
TN - Tunisia 48
PY - Paraguay 43
PH - Filippine 42
RO - Romania 39
AE - Emirati Arabi Uniti 38
IL - Israele 36
JO - Giordania 36
PE - Perù 34
EG - Egitto 33
BJ - Benin 32
KE - Kenya 31
AL - Albania 29
AZ - Azerbaigian 29
NP - Nepal 28
MY - Malesia 26
KZ - Kazakistan 24
BG - Bulgaria 23
DZ - Algeria 23
OM - Oman 22
PT - Portogallo 22
CR - Costa Rica 20
EU - Europa 20
UY - Uruguay 20
GR - Grecia 19
HR - Croazia 19
HU - Ungheria 19
LV - Lettonia 19
TH - Thailandia 19
KG - Kirghizistan 18
RS - Serbia 17
BO - Bolivia 16
JM - Giamaica 15
BY - Bielorussia 14
LU - Lussemburgo 14
PA - Panama 14
SI - Slovenia 14
ET - Etiopia 13
LB - Libano 13
AM - Armenia 12
DK - Danimarca 11
NZ - Nuova Zelanda 11
HN - Honduras 10
NO - Norvegia 10
DO - Repubblica Dominicana 8
QA - Qatar 8
SY - Repubblica araba siriana 8
TT - Trinidad e Tobago 8
BA - Bosnia-Erzegovina 7
GA - Gabon 7
KW - Kuwait 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
GT - Guatemala 6
LA - Repubblica Popolare Democratica del Laos 6
Totale 108.085
Salva come PNG Salva come JPEG
Città #
Southend 7.927
Singapore 5.407
Moscow 4.234
Chandler 4.011
Ashburn 3.808
Jacksonville 3.200
San Jose 3.102
Dallas 2.833
Woodbridge 2.348
Hong Kong 2.026
Dublin 1.632
Ann Arbor 1.551
Verona 1.524
The Dalles 1.294
Beijing 1.199
Houston 1.171
Milan 751
New York 704
Ho Chi Minh City 640
Lawrence 637
Munich 636
Princeton 636
Rome 630
Wilmington 626
Los Angeles 605
Jinan 583
Nanjing 535
Shenyang 444
Hanoi 425
Helsinki 415
Hebei 307
Sindelfingen 305
Buffalo 300
Tianjin 292
Tokyo 282
São Paulo 273
Santa Clara 261
Redondo Beach 238
Council Bluffs 230
Zhengzhou 221
Columbus 203
Haikou 202
Ningbo 197
Orem 185
Hangzhou 179
Redmond 175
Changsha 171
Boardman 168
Seattle 164
Bologna 162
Turku 162
Nanchang 158
Guangzhou 154
Lancaster 148
Taiyuan 140
London 133
Brussels 130
Florence 130
Montreal 130
Warsaw 128
Jiaxing 126
Taizhou 124
Frankfurt am Main 121
Abuja 118
Naples 116
Chennai 112
Brooklyn 106
Denver 105
Stockholm 103
Turin 103
Fairfield 97
Toronto 97
Falls Church 96
San Francisco 96
Atlanta 95
Amsterdam 94
Johannesburg 91
Da Nang 90
Norwalk 90
Nuremberg 90
Chicago 88
Rio de Janeiro 85
Catania 82
Lanzhou 81
Haiphong 78
Genoa 76
Seoul 75
Jakarta 74
Phoenix 73
Redwood City 73
Falkenstein 71
Belo Horizonte 70
Fuzhou 70
Vienna 70
Tashkent 68
Bari 67
Manchester 66
Washington 65
Poplar 61
Brescia 59
Totale 64.984
Salva come PNG Salva come JPEG
Nome #
L’infiltrazione vascolare della vena porta e/o mesenterica superiore è ancora segno di non resecabilità chirurgica nelle neoplasie del pancreas ? 7.477
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) 302
Resezione intermedia e pancreasectomia distale per neoplasie benigne del pancreas: confronto per complicanze postoperatorie e costi 282
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 282
Whole-genome landscape of pancreatic neuroendocrine tumours 280
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 256
Influenza del sito d’ infezione (pancreas) sulla farmacocinetica e farmacodinamica di piperacillina-tazobactam 253
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
Genomic analyses identify molecular subtypes of pancreatic cancer 251
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 247
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 246
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 245
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 245
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 241
[Bilemia: diagnosis and conservative treatment. Apropos of a case complicated by hepatic abscess]. 240
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 240
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 237
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 237
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 233
7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model 233
[Closed surgical treatment in acute severe pancreatitis] 232
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 232
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Gα15 in early onset of pancreatic ductal adenocarcinoma 232
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 230
Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. 229
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 229
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 225
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 225
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 224
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 223
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 222
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 221
A root-cause analysis of mortality following major pancreatectomy 221
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 218
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 218
Progetto integrato per la ricerca traslazionale nel carcinoma duttale del pancreas [Integrated project for the translational research on pancreatic ductal carcinoma] 217
Antibiotics penetration in human necrotizing pancreatitis (NP). 217
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 217
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 217
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 216
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer 215
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 215
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 214
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 214
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 214
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival. 213
[Cystic tumors of the pancreas: diagnosis, management and results] 213
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 213
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 212
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 212
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 211
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 211
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 210
Triple approach strategy for patients with locally advanced pancreatic carcinoma 210
RON is not a prognostic marker for resectable pancreatic cancer 209
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 209
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 208
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 208
SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and tumor growth in vito and in vivo. 207
Cystic tumors of the pancreas. Pathology 207
[A case of suppurated urachal cyst (clinical study)]. 207
Caso clinico: il diverticolo duodenale interno 206
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 206
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma 206
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 205
Clinical and Morphological Features of Paraduodenal Pancreatitis: An Italian Experience With 120 Patients 205
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 204
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 204
Laparoscopic distal pancreatectomy: results on a consecutive series of 58 patients. 203
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Delaying surgery for patients with a previous SARS-CoV-2 infection 202
Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. 201
Effect of alcohol and smoking on pancreatic lithogenesis in the course of chronic pancreatitis. 200
Acute pancreatitis at the beginning of the 21st century: the state of the art. 200
Use of Operative Sonography In Carcinoma of the Pancreas 200
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 200
Preliminary Microbiological and Antibiotic Kinetic-study On Prevention and Treatment of Pancreatic Infections 199
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy 199
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 199
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 197
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 196
Lactobacillus planctarum reduces infection of pancreatic necrosis in experimetal acute pancreatitis. 195
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 195
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 195
Autoimmune pancreatitis: possibilities of CT characterization. 194
Methylation Dynamics of RASSF1A and Its Impact on Cancer 194
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 194
Non-functioning Islet Cell Tumors - A Consideration of 8 Cases 193
Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation 193
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers 192
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 192
Pancreatic Hepatoid Carcinoma: A Review of the Literature 191
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 191
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 191
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. 190
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 190
Clinical Strategy In Severe Hemorrhage Due To Pancreatic Pseudocysts 190
IAP/APA evidence-based guidelines for the management of acute pancreatitis 190
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Totale 28.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 332.388
article - articoli 302.591
book - libri 1.160
conference - conferenze 15.873
curatela - curatele 0
other - altro 4.573
patent - brevetti 863
selected - selezionate 0
volume - volumi 7.328
Totale 664.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.231 0 0 0 0 0 0 0 0 0 172 705 354
2021/20225.456 472 1.253 128 358 256 276 140 322 264 154 527 1.306
2022/202312.530 847 1.204 1.134 2.015 1.018 2.790 294 978 1.345 200 398 307
2023/20246.742 371 619 612 817 719 849 410 515 121 326 918 465
2024/202515.831 1.013 1.002 585 2.465 942 581 972 913 2.192 998 1.374 2.794
2025/202640.714 3.090 2.069 3.084 6.664 10.435 3.098 4.064 2.382 3.575 2.253 0 0
Totale 109.122